Market Place
Sourcing Support
HanxBio Narazaciclib AML Preclinical Study Published
23 Apr 2024 //
PR NEWSWIRE
Onconova Therapeutics Narazaciclib Highlights Activity in Mantle Cell Lymphoma
12 Dec 2023 //
GLOBENEWSWIRE
Onconova`s Narazaciclib Data Highlights Anti-Tumor Activity v. Other CDK4/6i™s
08 Dec 2023 //
GLOBENEWSWIRE
Onconova Presents Data on Narazaciclib at the 17th International Conference
14 Jun 2023 //
GLOBENEWSWIRE
Onconova to Participate in R&D Showcase on Narazaciclib in Endometrial Cancer
12 May 2023 //
GLOBENEWSWIRE
Onconova doses first patient in trial of endometrial cancer combo therapy
12 May 2023 //
CLINICAL TRIALS ARENA
Onconova Doses First Patient in Phase 1/2a Trial of Narazaciclib with Letrozole
11 May 2023 //
GLOBENEWSWIRE
Onconova Announces the Presentation of New Preclinical Data on Narazaciclib
19 Apr 2023 //
GLOBENEWSWIRE
Onconova Therapeutics Announces Plans for a Phase 1/2a Trial of Narazaciclib
14 Nov 2022 //
GLOBENEWSWIRE
Onconova Announces Abstract at ASCO 2022 Highlighting Narazaciclib activity
26 May 2022 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.